HuMax-CD20 in Chronic Lymphocytic Leukemia
Clinical trial NCT00093314 · WITHDRAWN
Trial details
- NCT number
- NCT00093314
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2007-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.